Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » »

July 20, 2015 • Category • Author Name

Opal Biosciences CEO Interview, Wholesale Investor

Latest News

Results of GM

April 19, 2024

View Results of AGM

Read More
Notice of Meeting and Proxy Form

March 26, 2024

Notice of General Meeting on Friday, 19 April 2024 at 2.00pm (Melbourne time) read the full announcement.

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions